A.Vogel Antiviral Formula
50mL
$ 17.79
A.Vogel Antiviral Formula
Prevents and relieves symptoms associated with bacterial and viral infections.
| |||||||||||||||
More Info
Composition
EACH 4 DROP DOSE CONTAINS TINCTURE OF:
Echinacea*§ (Echinacea purpurea) herb (ratio 1:12) 79.5 mg, equivalent to 6.6mg herb.
Echinacea* § (Echinacea purpurea) root (ratio 1:11) 4.2 mg, equivalent to 0.38 mg root.
Lanceleaf Plantain* § (Plantago lanceolata) herb (ratio 1:12) 27.9 mg, equivalent to 2.3mg herb.
§ = fresh
Alcohol content: 1ml of tincture contains 0.62ml alcohol (ethanol).
*Certified organically grown by: Bio Suisse
Echinacea*§ (Echinacea purpurea) herb (ratio 1:12) 79.5 mg, equivalent to 6.6mg herb.
Echinacea* § (Echinacea purpurea) root (ratio 1:11) 4.2 mg, equivalent to 0.38 mg root.
Lanceleaf Plantain* § (Plantago lanceolata) herb (ratio 1:12) 27.9 mg, equivalent to 2.3mg herb.
§ = fresh
Alcohol content: 1ml of tincture contains 0.62ml alcohol (ethanol).
*Certified organically grown by: Bio Suisse
Dosage
Give drops in a small amount of water or juice.
Prevention: Take the dose once daily
Treatment : Take the dose 2 to 3 times daily
Dose for adults and children over 12: 15 drops
Dose for children 6-12 years: 8 drops
Dose for children 2-5 years: 4 drops
May be used for up to 16 days.
Prevention: Take the dose once daily
Treatment : Take the dose 2 to 3 times daily
Dose for adults and children over 12: 15 drops
Dose for children 6-12 years: 8 drops
Dose for children 2-5 years: 4 drops
May be used for up to 16 days.
Historical overview
A.Vogel
Antiviral Formula contains a lance-leaf plantain extract combined with
the same echinacea formula found in Echinaforce.
Long before the coming of the European settlers, the Amerindians used echinacea (also called purple cone flower) to treat all sorts of problems, from infections to snake bites. Echinacea was popularized by the eclectic physicians’ movement in the 19e century in United States. After that, in America, its use was almost forgotten until the 1980’s. In Europe, however, echinacea was in favour with the medical world from the beginning of the century and has been the object of numerous clinical researches. Nowadays, echinacea is the most sold medicinal herb in the whole world.
For centuries lance-leaf plantain (Plantago lanceolata) has been used around the world as a wound healer (vulnerary). Plantain was also used for respiratory conditions and infections, skin diseases and mucous membrane ulcerations and irritations.(1)
Despite the lack of clinical studies, most experts agree on the lack of toxicity of plantain and on its usefulness for upper respiratory tract infections.(2)
Long before the coming of the European settlers, the Amerindians used echinacea (also called purple cone flower) to treat all sorts of problems, from infections to snake bites. Echinacea was popularized by the eclectic physicians’ movement in the 19e century in United States. After that, in America, its use was almost forgotten until the 1980’s. In Europe, however, echinacea was in favour with the medical world from the beginning of the century and has been the object of numerous clinical researches. Nowadays, echinacea is the most sold medicinal herb in the whole world.
For centuries lance-leaf plantain (Plantago lanceolata) has been used around the world as a wound healer (vulnerary). Plantain was also used for respiratory conditions and infections, skin diseases and mucous membrane ulcerations and irritations.(1)
Despite the lack of clinical studies, most experts agree on the lack of toxicity of plantain and on its usefulness for upper respiratory tract infections.(2)
Actions and pharmacology
In vitro studies have allowed the discovery of echinacea’s action
mechanism: its polysaccharides and polyacetylenes fractions stimulate
the phagocytosis of macrophages (immune system cells) and the
production of cytokines (messengers of the immune system) like
interleukine-1, interleukine-6 (also called interferon beta),
interleukine-10 and TNF alpha factor. This effect shows echinacea’s
ability to stimulate the immune system in cases of infection.(3) In
simple terms, echinacea stimulates the non-specific immune system,
increasing its ability to fight infections.
Chicoric acid and analogues derived from caffeic acid are presently under investigation for their effect on VIH-1 replication.(4)
Echinacea, particularly the echinacosides and caffeic acid derivatives, might protect collagen structures against degradation (oxidation) caused by free radicals. This antioxidant effect is also useful to relieve the inflammation generated by the immune system during its fight against the viruses of cold.
The German E Commission recognizes the use of echinacea for supportive therapy for colds and chronic infections of the respiratory tract.
Lance-leaf plantain contains polysaccharides that provide a light immune stimulation and a capacity to cling to the mucous membrane.(1,5) In addition, plantain is a source of antioxidant caffeic acid, of anti-inflammatory flavonoids (e.g. luteolin)(6), and of immunomodulating and anti-ulcer iridoid glycosides and terpenoids.(1,7)
The German E Commission recognizes the use of lance-leaf plantain (Plantago lanceolata) for catarrhs of the respiratory tract, for inflammatory alteration of the oral and pharyngeal mucosa and, externally, for skin inflammations.
Chicoric acid and analogues derived from caffeic acid are presently under investigation for their effect on VIH-1 replication.(4)
Echinacea, particularly the echinacosides and caffeic acid derivatives, might protect collagen structures against degradation (oxidation) caused by free radicals. This antioxidant effect is also useful to relieve the inflammation generated by the immune system during its fight against the viruses of cold.
The German E Commission recognizes the use of echinacea for supportive therapy for colds and chronic infections of the respiratory tract.
Lance-leaf plantain contains polysaccharides that provide a light immune stimulation and a capacity to cling to the mucous membrane.(1,5) In addition, plantain is a source of antioxidant caffeic acid, of anti-inflammatory flavonoids (e.g. luteolin)(6), and of immunomodulating and anti-ulcer iridoid glycosides and terpenoids.(1,7)
The German E Commission recognizes the use of lance-leaf plantain (Plantago lanceolata) for catarrhs of the respiratory tract, for inflammatory alteration of the oral and pharyngeal mucosa and, externally, for skin inflammations.
Scientific studies
Many clinical studies demonstrate echinacea’s efficacy as an immune
system stimulant.(8-10) According to the authors of an important
meta-analysis (a review of articles on clinical studies), echinacea is
effective against respiratory infections, especially if taken as soon
as the first symptoms appear.(11)
Echinaforce has also been the object of conclusive clinical studies:
A double-blind placebo-controlled study was conducted in Sweden on Echinaforce tablets. 246 patients suffering from cold took either 6 Echinaforce tablets daily, or a special preparation (7 times more concentrated), or another form of echinacea, or a placebo. Echinaforce and the concentrated preparation have been equally effective to reduce cold symptoms and significantly more effective than placebo or the other preparation.(12)
Another study conducted on 119 patients has demonstrated a 60% improvement of cold symptoms with Echinaforce tablets compared to placebo.(13)
A recent study (April 2002) on 48 volunteers shows that echinacea significantly increases one of the markers of immune system stimulation: properdine.(14)
There are no published clinical studies on plantain at the moment (Medline). However, plantain is recognized in Germany for its anti-inflammatory, antispasmodic and immunostimulating virtues. Since it doesn’t show any toxicity and is side effect free, it is recommended mostly for children for irritation and inflammations of the respiratory tract mucosa characterized by cough.(2)
Echinaforce has also been the object of conclusive clinical studies:
A double-blind placebo-controlled study was conducted in Sweden on Echinaforce tablets. 246 patients suffering from cold took either 6 Echinaforce tablets daily, or a special preparation (7 times more concentrated), or another form of echinacea, or a placebo. Echinaforce and the concentrated preparation have been equally effective to reduce cold symptoms and significantly more effective than placebo or the other preparation.(12)
Another study conducted on 119 patients has demonstrated a 60% improvement of cold symptoms with Echinaforce tablets compared to placebo.(13)
A recent study (April 2002) on 48 volunteers shows that echinacea significantly increases one of the markers of immune system stimulation: properdine.(14)
There are no published clinical studies on plantain at the moment (Medline). However, plantain is recognized in Germany for its anti-inflammatory, antispasmodic and immunostimulating virtues. Since it doesn’t show any toxicity and is side effect free, it is recommended mostly for children for irritation and inflammations of the respiratory tract mucosa characterized by cough.(2)
Precautions, contraindications and interactions
Avoid taking in case of known allergy to Asteraceae / Compositae (daisy) family.
Consult a health care practitioner prior to use in cases of auto-immune disorders, tuberculosis, leukemia, multiple sclerosis or HIV-infection (AIDS) or use of immunosuppressants.
Consult a health care practitioner if symptoms persist.
Do not use if security cap is broken.
Keep out of the reach of children.
Consult a health care practitioner prior to use in cases of auto-immune disorders, tuberculosis, leukemia, multiple sclerosis or HIV-infection (AIDS) or use of immunosuppressants.
Consult a health care practitioner if symptoms persist.
Do not use if security cap is broken.
Keep out of the reach of children.
References
1-Samuelsen AB. The traditional uses, chemical constituents and
biological activities of Plantago major L. A review. J
Ethnopharmacol 2000 Jul;71(1-2):1-21
2-Wegener T, Kraft K. [Plantain (Plantago lanceolata L.): anti-inflammatory action in upper respiratory tract infections] [Article in German]. Wien Med Wochenschr 1999;149(8-10):211-6
3-Burger Ra, Torres AR, Warren RP et al. Echinacea-induced cytokine by human macrophages. Int J Immunopharmacol 1997;19(7):371-9.
4-Lin Z, Neamati N, Zhao H et al. Chicoric acid analogues as HIV-1 integrase inhibitors. J Med Chem 1999;42(8):1401-14.
5-Schmidgall J, Schnetz E, Hensel A. Evidence for bioadhesive effects of polysaccharides and polysaccharide-containing herbs in an ex vivo bioadhesion assay on buccal membranes. Planta Med 2000 Feb;66(1):48-53
6-Murai M, Tamayama Y, Nishibe S. Phenylethanoids in the herb of Plantago lanceolata and inhibitory effect on arachidonic acid-induced mouse ear edema. Planta Med 1995 Oct;61(5):479-80
7-Taskova R, Evstatieva L, Handjieva N et al. Iridoid patterns of genus Plantago L. and their systematic significance. Z Naturforsch [C] 2002 Jan-Feb;57(1-2):42-50
8-Gunning K. Echinacea in the treatment and prevention of upper respiratory tract infections. West J Med 1999;171:198-200.
9-Barrett B, Vohmann M, Calabrese C. Echinacea for upper respiratory infection. J Fam Pract 1999;48:628-35.
10-Grimm W, Muller HH. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 1999;106:138-43.
11-Barrett B, Vohmann M et Calabrese C. Echinacea for Upper respiratory infection. J Fam Pract 1999;48(8):628-35.
12-Brinkeborn RM, Shah DV, Degenring FH. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial. Phytomedicine 1999 Mar;6(1):1-6
13-Brinkeborn RM, Shah DV, Geissbühler S, Degenring FH. Echinaforce dans le traitement des états grippaux aigus. Schweiz Zschr GanzheitsMedizin 1998;10(1):26-9.
14-Kim LS, Waters RF, Burkholder PM. Immunological activity of larch arabinogalactan and Echinacea: A preliminary, randomized, double-blind, placebo-controlled trial. Altern Med Rev 2002 Apr;7(2):138-149.
2-Wegener T, Kraft K. [Plantain (Plantago lanceolata L.): anti-inflammatory action in upper respiratory tract infections] [Article in German]. Wien Med Wochenschr 1999;149(8-10):211-6
3-Burger Ra, Torres AR, Warren RP et al. Echinacea-induced cytokine by human macrophages. Int J Immunopharmacol 1997;19(7):371-9.
4-Lin Z, Neamati N, Zhao H et al. Chicoric acid analogues as HIV-1 integrase inhibitors. J Med Chem 1999;42(8):1401-14.
5-Schmidgall J, Schnetz E, Hensel A. Evidence for bioadhesive effects of polysaccharides and polysaccharide-containing herbs in an ex vivo bioadhesion assay on buccal membranes. Planta Med 2000 Feb;66(1):48-53
6-Murai M, Tamayama Y, Nishibe S. Phenylethanoids in the herb of Plantago lanceolata and inhibitory effect on arachidonic acid-induced mouse ear edema. Planta Med 1995 Oct;61(5):479-80
7-Taskova R, Evstatieva L, Handjieva N et al. Iridoid patterns of genus Plantago L. and their systematic significance. Z Naturforsch [C] 2002 Jan-Feb;57(1-2):42-50
8-Gunning K. Echinacea in the treatment and prevention of upper respiratory tract infections. West J Med 1999;171:198-200.
9-Barrett B, Vohmann M, Calabrese C. Echinacea for upper respiratory infection. J Fam Pract 1999;48:628-35.
10-Grimm W, Muller HH. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 1999;106:138-43.
11-Barrett B, Vohmann M et Calabrese C. Echinacea for Upper respiratory infection. J Fam Pract 1999;48(8):628-35.
12-Brinkeborn RM, Shah DV, Degenring FH. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial. Phytomedicine 1999 Mar;6(1):1-6
13-Brinkeborn RM, Shah DV, Geissbühler S, Degenring FH. Echinaforce dans le traitement des états grippaux aigus. Schweiz Zschr GanzheitsMedizin 1998;10(1):26-9.
14-Kim LS, Waters RF, Burkholder PM. Immunological activity of larch arabinogalactan and Echinacea: A preliminary, randomized, double-blind, placebo-controlled trial. Altern Med Rev 2002 Apr;7(2):138-149.
Brand
Product Assortment
Ailments
